Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer

Scope

 

The Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC) was formed to undertake a comprehensive clinical, epidemiological, and biological characterization of patients with Chronic Pancreatitis (including those with Acute Recurrent Pancreatitis, ARP) to gain insight into the pathophysiology of chronic pancreatitis and its sequela: chronic pain, pancreatic insufficiency, T3cDM and the diabetes/pancreatic cancer association.

 

The multidisciplinary teams will also undertake studies on the development of pancreatic cancer in newly diagnosed diabetic patients.

 

 

Focus

 

Research results are shared freely within Consortium to develop trans-Consortium collaborative projects that make use of the combined expertise and technological capabilities present in all of the Clinical Centers.

 

Through the acquisition of a cohort of well-characterized patients and associated biospecimens (blood, pancreatic and duodenal juice, stools and when feasible pancreatic tissue), the proposed clinical research network will provide the resources and collaborative opportunities necessary for achieving many of the research objectives identified in the strategic plans of the participating institutes.

 

 

Objectives

 

The overriding two objectives of this research program are to pursue clinical research

 

•on Chronic Pancreatitis (including those with Acute Recurrent pancreatitis, ARP), by identifying and characterizing a large cohort of pediatric and adult patients with CP and ARP to encourage translational research focusing upon elucidating the pathogenesis that will provide the basis for understanding the natural history and developing means of diagnosis, treatment and clinical management of Chronic Pancreatitis and its sequela: chronic pain, pancreatic insufficiency and

 

•on pancreatic cancer and pancreatogenic Diabetes Mellitus (T3cDM) and their pathogenic interrelationships, by identifying and following a cohort of newly diagnosed diabetic patients in the setting of CP.

© Consortium for the Study of Chronic Pancreatits, Diabetes, and Pancreatic Cancer